Bioengineer: Stanley Hazen, a molecular medicine professor at Cleveland Clinic Lerner College of Medicine, commented on a study he and his colleagues conducted that uncovered a new pathway linked to high amounts of niacin, a popular B vitamin that was previously recommended to lower cholesterol, and cardiovascular disease. “What’s exciting about these results is that this pathway appears to be a previously unrecognized yet significant contributor to the development of cardiovascular disease,” he said.
